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Summary: Using 231 amniotic fluid samples from a Regional Screening Service, the performance of a
monoclonal antibody-based solid-phase immunoradiometric assay (IRMA) for α-fetoprotein was compared
with that of a polyclonal antiserum-based solution phase radioimmunoassay (RIA). α-Fetoprotein values
determined from these samples by the two methods were in excellent agreement (r = 0.992) and the diagnostic
performance of the two assays was identical. However, the IRMA assay displayed a greater working r nge
than the RIA, and in addition was more rapid to perform, allowing within-day turnaround of laboratory
results.
Vergleich eines innerhalb eines Tages abgeschlossenen immunradiometrischen Festphasen-Assay mit einem in
L sung ablaufenden Radioimmunoassay zur Bestimmung von a-Fetoprotein in Fruchtwasser
Zusammenfassung: Wir verglichen an 231 Fruchtwasserproben aus einer regionalen Vorsorgeuntersuchung
die Handhabung eines immunradiometrischen Festphasenassay (IRMA) auf Grundlage eines monoklonalen
Antik rpers mit der eines in L sung ablaufenden Radioimmunassay (RIA) auf Grundlage eines polyklonalen
Antiserums. Die mit beiden Methoden bestimmten Werte f r α-Fetoprotein stimmen hervorragend berein
(r = 0,992) und die diagnostische Brauchbarkeit beider Verfahren war gleichwertig.
Der immunradiometrische Assay er ffnet jedoch einen h heren Arbeitsbereich als der Radioimmunassay
und ist zus tzlich schneller durchzuf hren, so da die Ergebnisse innerhalb eines Tages vorliegen und
verwendet werden k nnen.
Introduction Materials and Metbods
A new, commerci lly available, solid-phase iminuno- α-Fetoprotein analyses
radiometric assay (IRMA) for the quantification of Amniotic fluid α-fetoprotein (AFP) was estimated by two tech-
amniotic fluid α-fetoprotein h s been compared with mqu»:
a sol tion-phase radioimmunoassay (RIA) which has IRMA (SUCROSEP1) AFP IRMA, Boots-Celltech Diag-
been the ro tine assay used by the Wessex Regional nostics Limited, Slough, U.K.)
Amniotic fluid α-fetoprotein screening laboratory for This immunoradiometric assay (IRMA) was perfonned using
three vears the manufacturer's recommended protocol: α-fetoprotein stan-
^ dard or unknown sample (50 μΐ) is incubated for two hours at
The purpose of this study was to evaluate the labora- ~om temperature (15-30 °C) with '25I-labelled'monoclonal
j -. . - ~ ^ t . T - O X ^ A anUbody to a-fetoprotein (100 μΐ) and solid phase anti-a-
tory and climcal performance of the new IRMA, fetoprotein immunoglobulin (100 μΐ). Throughout this incuba-
which incorporates a monoclonal ntibody to α-feto-
protein and requires only a two-hour incubation pe- i) SUCROSEP is a trademark of Boots-Celltech Diagnostics
riod thus permitting a within-day assay Service. Limited.
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tion, vigorous Orbital agitation (300 — 350 min"1) is provided
using an agitator (Sucroagitator, Boots-Celltech Diagnostics
Limited).
At the end of the incubation phase, Separation of free and
bound fractions is achieved by the SUCROSEP sucrose layering
non-centrifugation technique (1) using a semi-autoraatic instru-
ment (Sucroseparator, Boots-Celltech Diagnostics Limited).
This allows assay tubes to be rapidiy separated in 20-tube
batches. The overall time taken for assay Separation is approxi-
mately 50 minutes.
RIA (AFP RIA, IM98 Amersham International plc, Amer-
sham, U.K.)
This solution phase radioimmunoassay (RIA) was also per-
formed using the manufacturer's recommended protocol except
that half volume of samples and reagents were employed (the
practice in our laboratory for the last 3 years). The assay
procedure incorporates an 18 — 24 hour incubation of [125Γ|α-
fetoprotein and antibody with α-fetoprotein Standard or sam-
ple, and Separation of bound and free fractions is achieved by
polyethylene glycol precipitation and centrifugation.
Sample analysis
Immediately before assay, each amniotic fluid was diluted with
a serum pool of zero α-fetoprotein content. Normally a l in
200 dilution was used, but occasionally a higher dilution amni-
otic fluid sample was used for both immunoassays and the
batches for the two techniques were commenced on the same
day. Each amniotic fluid was assayed in duplicate by both
techniques.
Calculation of assay results and conversion of a-
fetoprotein units
The radioactivity in all the assay tubes was counted on a
multihead gamma counter (LKB 1260 multigamma II) over a
120 second period. α-Fetoprotein values for clinical specimens
from both assays were calculated for kU/1 by spline function.
The following conversion factor was used for RIA results:
l I.U. = 1.21 ng α-fetoprotein [90% confidence interval =
1.02—1.43] (2). These values were then corrected for the sample
dilution factor and expressed s MU/1 α-fetoprotein.
Amniotic fluid samples
231 aliquot s of amniotic fluid were studied. These were taken
by transabdominal amniocentesis during the second trimester
of pregnancy for a variety of clinical indications. These samples
were centrifuged and the supernatant either used immediately
or stored at —20 °C until analysis.
Normal pregnancies
116 liquors from normal pregnancies were studied. For these
pregnancies ultrasound examination revealed no obvious fetal
abnormality. The amniotic fluid α-fetoprotein by RIA was
within normal laboratory reference limits and there was no
evidence of the acetyl cholinesterase isoenzyme band on polyac-
rylamide gel electrophoresis (3, 4).
Abnormal pregnancies
109 samples were classified s 'abnormal'. These pregnancies
had been terminated and the fetuses conflrmed to have a severe
fetal abnormality [54 open spina bifida, 32 anencephaly, 14
exomphalos, 2 gastroschisis, 7 missed abortioii].
'Eq ivocal pregnancies'
Six samples were also included from 'equivocal pregnancies9
for which the outcome of the pregnancy was a normal infant
but the amniotic fluid α-fetoprotein concentration by RIA was
either borderline high or significantly elevated.
Statistical methods
Precision profile data (flg. 1) were generated using a 5-para-
meter curve fitting procedure provided by Boots-Celltech Diag-
nostics Limited. All other Statistical analysis were perf rmed
by using the Minitab Statistics Package2).
Results
Assay reproducibility
The overall reproducibility of the IRMA was greater
than that of the RIA. The intra- and inter>assay
coefficients of Variation (CV) for the RIA and IRMA
are shown in table 1. The greater analytical precision
of the IRMA was most noteable at α-fetoprotein
concentrations above ~ 200 kU/1, and is apparent
from a comparison of intra-assay precision profiles
(fig. 1). Using a definition of the working r nge
of each assay to be the α-fetoprotein concentration
associated with an intra-assay CV of < 10%, the
IRMA and RIA covered ranges of 3^629 kU/1
and 30—363 kU/1 respectively.
The relationship between amniotic fluid a-
fetoprotein levels measured by IRMA and
RIA
As shown in figure 2, α-feiojlrotein values by IRMA
and RIA correlated very well (n = 231, r = 0.992,
IRMA = 1.06 RIA-2.35). Howevef at α-fetoprotein
concentrations above 200 M /1 there appeared to be
a slight divergence of results with an apparent positive
bias towards the IRMA assay.
Clinical performance of IRMA
The median α-fetoprotein concentration and r nge
determined by IRMA for each gestational age of the
normal population studied is shown in table 2.
Figure 3 illustrates the α-fetoprotein results obt ined
by IRMA for the 109 abnormal amniotic fluids in
relation to the median and multiple of the inedian
cut-off levels of the normal population (5). Using
these IRMA results, all of the cases of anencephaly,
exomphalos, gastroschisis or missed ' bortion (gesta-
tional ages between 15 and 20 weeks) were correctly
classified s abnormal (greater than the respective
multiple of the inedian (MOM) cut-off level).- - - .. »
*) Minitab is a trademark of Minitab*Inc; Pennsylvania, USA.
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Tab. 1. Assay rcproducibiiity of RIA and IRMA (tntra- and inter-assay) bascd on repeatcd analyses of conlrol pools. (Prior to
assay, samplcs l and 2 were diluted 1/200, sample 3 was diluted 1/400).
Sample %CV
Mcan α-fetoprotcin concentration (MU/1) Intra-assay Inter-assay
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Fig. 3. α-Fetoprotein values for 109 abnormal amniotic fluid
samples measured by IRMA)
V Spina bifida;
A Anencephalic;




Recommended multiple of the median cut-off
level (5).
Tab. 2. cc-Fetoportein concentrations of 116 amniotic fluids from normal pregnancies s measured by IRMA.
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Fig. 2. Relationship between α-fetoprotein values detennined
by IRMA and RIA for 231 amniotic fluid samples.
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These test outcomes based on the IRMA exactly
agreed with the classification given by the reference
RIA technique. The amniotic fluid α-fetoprotein con-
centration of 46 of the 52 (88.5%) cases of open spina
bifida (gestational age 15-20 weeks) was also greater
than the respective multiple of the median cut off
levels using the IRMA assay. The remaining 6 cases
of open spina bifida had α-fetoprotein values by
IRMA which feil below the multiple of the median
cut off (false negative results). These same 6 cases
were similarly misclassified using the RIA technique.
Finally, in the further 6 samples from 'equivocal
pregnancies' in which the outcome was in each case
a normal infant, the α-fetoprotein level by IRMA
was borderline or elevated, again in accordance with
the results of the routine RIA.
Discussion
Using amniotic fluid samples collected s part of a
regional screening Service, α-fetoprotein values deter-
mined by a new, commercially available IRMA were
in excellent agreement (r = 0.992) with those deter-
mined using the RIA in routine use. However, it was
noted that agreement between the two methods was
less close at higher levels of α-fetoprotein (> 200
kU/1), with an apparent positive bias towards the
IRMA at these elevated concentrations.
Although this divergence did not affect the clinical
Utility of either assay, which was excellent in both
cases, it is of interest to consider its possible origin
more fully. Examination of the intra-assay precision
profiles of the RIA and IRMA (fig. 1) reveals that
the working r nge of the IRMA is considerably wider
than that of the RIA. This wide working r nge, a
general feature of IRMAs noted 'by others (e. g. L c.
(6)), indicates that at high α-fetoprotein concentra-
tions the analytical precision of the IRMA is mark-
edly greater than that of the RIA. Thus the observed
divergence of c^fetoprotein results at the high extreme
may, at least in part, be attributable to the relative
imprecision of the RIA.
The ability to measure^ using an IRMA, both low
and high α-fetoprotein concentrations with similar
precision and accuracy may be important and desu>
able, especially in view of recent interest in the associ-
ation between low maternal serum and amniotic fluid
α-fetoprotein and Dowrfs syndrome (7).
In summary, the IRMA proved to be a practical,
robust and convenient assay for the determination of
amniotic fluid α-fetoprotein in a routine laboratory.
Though the diagnostic performance of both the
IRMA and the RIA was identical, in our opinion the
IRMA displayed a number of analytical advantages
— noteably an extended working r nge, providing
greater confidence at elevated α-fetoprotein values.
Furthermore, the IRMA's rel tively short incubation
tinie (2 h versus 18h + for the RIA) allows for the
convenience of within-day turnaround of laboratory
results.
References
1. Wright, J. F. & Hunter, W. M. (1983) 'The sucrose layering
Separation: A non-centrifugation System'. In: Immunoassays
for Clinical Chemistry (Hunter, W. M. & Corrie, J. E. T.,
eds.) Edinburgh: Churchill Livingstone.
2. (1979) Equivalence between international units and mass
units of α-foetoprotein. Report of a collaborative study.
Clin. Chim. Acta 96, 59-65.
3. Chubb, I. W., Pilowsky, P. M., Springwell, H. J. & Pollard,
A. C. (1979) Lancet /, 688-690.
4. Smith, A. O., Wald, N. J., Cuckle, H. S., Stirrat, G. M.,
Bobrow, M. & Lagercrantz, H. (1979) Lancet /, 685-688.
5. (1979) "Amniotic fluid alphafetoprotein measurement in an-
tenatal diagnosis of anencephaly and open spina bifida in
early pregnancy". Second report of the UK Collaborative
Study on alphafetoprotein in relation to rieural tube defects.
Lancet//, 651-661.
6. Hunter, W. M., Bennie, J. G., Budd, P. S., van Heyningen,
V., James, K., Micklem, R. L. & Scott, A. (1983) "Immuno-
radiometric assays using monoclonal antibqdies". In: Immu-
noassays for Clinical Chemistry (Hunter, W. M. & Corrie,
J.E. T., eds.) pp. 531-544. Edinburgh: Churchill Living-
stone.
7. Editoriai (1985) "Low matemal serum alpha fetoprotein and
Down's syndrome". Lancet /, 252—260.
E. J. Coombes





J. Clin. Chem. Clin. Biochem. / Vol. 24,1986 / N . 6
